Overview

Evaluate the Onset of Action of SKY0402 Following Local Infiltration in Healthy Volunteers

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
Given as a single perioperative injection, SKY0402 could provide adequate, continuous, and extended pain relief that could greatly simplify postoperative pain management, reduce the need for repeated administration, and minimize episodes of breakthrough pain.
Phase:
Phase 1
Details
Lead Sponsor:
Pacira Pharmaceuticals, Inc